Patients, carers and members of the public bring valuable views and the lived experience to research. This ensures new or better treatments meet the needs of patients. We aim to involve patients and the public in research as active partners and in all stages in the development of novel treatment approaches at the Blood and Transplant Research Unit (BTRU) in Stem Cells and Immunotherapies at UCL.
Patient & Public Involvement in lab-based and early clinical research workshop for researcher and Patient & Public Research Panel members on 12 March 2021
Our dedicated Patient and Public Research Panel members and other Patient Advisory Groups provide valuable insights to ongoing research in our unit. Our Patient & Public Research Panel consists of ten members adding a wealth of skills and experiences to stem cell and immunotherapy research to better treat cancer of the blood and lymph nodes as well as inherited genetic disorders.
Working with our Patient & Public Research Panel members on ways to integrate Patient and Public Involvement in the proposed research was very rewarding and led to some novel ideas to add real value to our programme. – Professor Karl Peggs, Co-Director of the UCL BTRU
Visit our news and events page about upcoming opportunities to meet UCL BTRU team members and updates on our work.
If you have any questions about Patient and Public Involvement and Engagement (PPIE), please contact Linda von Neree (PPIE Lead) at email@example.com or 020 3108 7641
- Examples of our Patient and Public Research Panel being involved in research as part of the Translational Research Office report: Celebrating 10 successful years (March 2021), page 14
- Blog post about Patient and Public Involvement (PPI) in advanced therapies (new medical products such as cell and gene therapies or tissue engineering) webinar on 29 April 2021
- Blog post about Patient and Public Involvement in our funding extension application